Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect any organ in the body. One of the main complications of this disease is lupus nephritis (LN), which occurs in 50% of patients with SLE. The standard of induction treatment consists of Corticosteroids plus immunosuppressants such as Cyclophosphamide or Mycophenolate Mofetil (MMF). Achieving remission correlates with long-term renal survival.
No takes yet. Share an insight, caveat, or question.
Cajas et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: